Global Information
회사소개 | 문의 | 비교리스트

세계의 차세대 시퀀싱(NGS) 샘플 조제 시장 : 워크플로우별, 용도별, 최종사용자별, 지역별 예측(-2026년) - COVID-19의 누적 영향

Next-Generation Sequencing Sample Preparation Market Research Report by Workflow, by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2021년 11월 상품 코드 1035719
페이지 정보 영문 185 Pages
가격
US $ 3,949 ₩ 4,748,000 Online Access (Single User License - 1 Year)
US $ 4,949 ₩ 5,951,000 PDF (Single User License) + Excel
US $ 5,949 ₩ 7,153,000 PDF (1-5 User License) + Excel
US $ 7,949 ₩ 9,558,000 PDF (Site License) + Excel
US $ 9,949 ₩ 11,963,000 PDF (Enterprise License) + Excel


세계의 차세대 시퀀싱(NGS) 샘플 조제 시장 : 워크플로우별, 용도별, 최종사용자별, 지역별 예측(-2026년) - COVID-19의 누적 영향 Next-Generation Sequencing Sample Preparation Market Research Report by Workflow, by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
발행일 : 2021년 11월 페이지 정보 : 영문 185 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 차세대 시퀀싱(NGS) 샘플 조제 시장 규모는 2020년에 32억 4,134만 달러로 평가되었으며, 2021년에는 37억 1,296만 달러에 이르고, 그 이후 연평균 복합 성장률(CAGR) 14.88%로 성장을 지속하여 2026년에는 74억 5,389만 달러에 달할 것으로 예상되고 있습니다.

세계의 차세대 시퀀싱(NGS) 샘플 조제 시장에 대해 조사했으며, 시장 기회와 과제, 성장 촉진요인 및 억제요인, COVID-19의 누적 영향, 워크플로우·용도·최종사용자·지역별 시장 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 제공합니다.

목차

제1장 서문

  • 조사 목적
  • 시장 세분화와 범위
  • 조사 대상년도
  • 통화와 가격
  • 언어
  • 제한 사항
  • 전제조건
  • 이해관계자

제2장 조사 방법

  • 정의 : 조사 목적
  • 결정 : 조사 계획
  • 준비 : 조사 기기
  • 수집 : 데이터 소스
  • 분석 : 데이터 해석
  • 책정 : 데이터 검증
  • 공개 : 조사 보고서
  • 반복 : 보고서 업데이트

제3장 개요

제4장 시장 개요

제5장 시장 인사이트

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제
  • COVID-19의 누적 영향

제6장 워크플로우별 차세대 시퀀싱 샘플 조제 시장

  • 자동 라이브러리 조정
  • 클론 증폭
  • NGS 라이브러리 조정 키트
  • 반자동 라이브러리 조정

제7장 용도별 차세대 시퀀싱 샘플 조제 시장

  • 애그리게노믹스 및 포렌식
  • 임상조사
  • 소비자 게노믹스
  • HLA Typing/면역 시스템 모니터링
  • 메타게노믹스, 역학 및 의약품 개발
  • 종양학
  • 생식건강

제8장 최종사용자별 차세대 시퀀싱 샘플 조제 시장

  • 학술연구
  • 임상연구
  • 병원/클리닉
  • 제약 기업/바이오테크놀러지 기업

제9장 아메리카의 차세대 시퀀싱 샘플 조제 시장

  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

제10장 아시아태평양의 차세대 시퀀싱 샘플 조제 시장

  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 싱가포르
  • 한국
  • 대만
  • 태국

제11장 유럽, 중동 및 아프리카의 차세대 시퀀싱 샘플 조제 시장

  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트(UAE)
  • 영국

제12장 경쟁 구도

  • FPNV 포지셔닝 매트릭스
    • 상한
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 주요 기업별 시장 점유율 분석
  • 경쟁 시나리오
    • 인수합병(M&A)
    • 합의/협업/파트너십
    • 신제품 발매와 강화
    • 투자 및 펀딩
    • 평가/인지/확대

제13장 기업 개요

  • Agilent Technologies, Inc.
  • BGI
  • Bio-Rad Laboratories, Inc.
  • CLC Bio
  • Eurofins GATC Biotech GmbH
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Foundation Medicine, Inc.
  • GnuBio
  • Illumina, Inc.
  • Knome, Inc.
  • Life Technologies Corp.
  • Macrogen, Inc.
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • Perkin Elmer, Inc.
  • PierianDx
  • Qiagen
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific, Inc.

제14장 부록

  • 디스커션 가이드
  • 라이선스와 가격
LSH 21.11.22

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET: MARKET DYNAMICS
  • FIGURE 3. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2020 VS 2026 (%)
  • FIGURE 4. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2020 VS 2026 (USD MILLION)
  • FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2026
  • FIGURE 6. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED LIBRARY PREPARATION, 2018-2026 (USD MILLION)
  • FIGURE 7. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED LIBRARY PREPARATION, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 8. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLONAL AMPLIFICATION, 2018-2026 (USD MILLION)
  • FIGURE 9. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLONAL AMPLIFICATION, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS LIBRARY PREPARATION KITS, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS LIBRARY PREPARATION KITS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SEMI-AUTOMATED LIBRARY PREPARATION, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SEMI-AUTOMATED LIBRARY PREPARATION, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 15. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 17. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AGRIGENOMICS & FORENSICS, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AGRIGENOMICS & FORENSICS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL INVESTIGATION, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL INVESTIGATION, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CONSUMER GENOMICS, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CONSUMER GENOMICS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HLA TYPING/IMMUNE SYSTEM MONITORING, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HLA TYPING/IMMUNE SYSTEM MONITORING, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, EPIDEMIOLOGY & DRUG DEVELOPMENT, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, EPIDEMIOLOGY & DRUG DEVELOPMENT, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 32. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2026
  • FIGURE 34. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2026 (USD MILLION)
  • FIGURE 35. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 36. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL RESEARCH, 2018-2026 (USD MILLION)
  • FIGURE 37. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 38. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2026 (USD MILLION)
  • FIGURE 39. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PHARMA & BIOTECH ENTITIES, 2018-2026 (USD MILLION)
  • FIGURE 41. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PHARMA & BIOTECH ENTITIES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 42. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 43. ARGENTINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 44. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 45. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 46. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 47. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 48. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 49. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 50. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 51. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 52. INDONESIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 53. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 54. MALAYSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 55. PHILIPPINES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 56. SINGAPORE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 57. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 58. TAIWAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 59. THAILAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 60. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 61. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 62. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 63. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 64. NETHERLANDS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 65. QATAR NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 66. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 67. SAUDI ARABIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 68. SOUTH AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 69. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 70. UNITED ARAB EMIRATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 71. UNITED KINGDOM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 72. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET: FPNV POSITIONING MATRIX
  • FIGURE 73. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 74. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2026 (USD MILLION)
  • TABLE 4. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED LIBRARY PREPARATION, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 5. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLONAL AMPLIFICATION, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 6. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS LIBRARY PREPARATION KITS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 7. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SEMI-AUTOMATED LIBRARY PREPARATION, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 8. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
  • TABLE 9. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AGRIGENOMICS & FORENSICS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 10. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL INVESTIGATION, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 11. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CONSUMER GENOMICS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 12. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HLA TYPING/IMMUNE SYSTEM MONITORING, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 13. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, EPIDEMIOLOGY & DRUG DEVELOPMENT, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 14. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 15. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 16. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
  • TABLE 17. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 18. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 19. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 20. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PHARMA & BIOTECH ENTITIES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 21. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 22. ARGENTINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 23. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 24. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 25. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 26. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 28. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 29. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 30. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 31. INDONESIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 32. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 33. MALAYSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 34. PHILIPPINES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 35. SINGAPORE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 36. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 37. TAIWAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 38. THAILAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 39. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 40. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 41. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 42. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 43. NETHERLANDS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 44. QATAR NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 45. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 46. SAUDI ARABIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 47. SOUTH AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 48. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 49. UNITED ARAB EMIRATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 50. UNITED KINGDOM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 51. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET: SCORES
  • TABLE 52. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET: BUSINESS STRATEGY
  • TABLE 53. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET: PRODUCT SATISFACTION
  • TABLE 54. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET: RANKING
  • TABLE 55. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 56. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET: MERGER & ACQUISITION
  • TABLE 57. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 58. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 59. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET: INVESTMENT & FUNDING
  • TABLE 60. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 61. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET: LICENSE & PRICING

The Global Next-Generation Sequencing Sample Preparation Market size was estimated at USD 3,241.34 million in 2020 and expected to reach USD 3,712.96 million in 2021, at a CAGR 14.88% to reach USD 7,453.89 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Next-Generation Sequencing Sample Preparation to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Workflow, the market was studied across Automated Library Preparation, Clonal Amplification, NGS Library Preparation Kits, and Semi-automated Library Preparation.
  • Based on Application, the market was studied across Agrigenomics & Forensics, Clinical Investigation, Consumer Genomics, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Oncology, and Reproductive Health.
  • Based on End User, the market was studied across Academic Research, Clinical Research, Hospitals & Clinics, and Pharma & Biotech Entities.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Next-Generation Sequencing Sample Preparation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Next-Generation Sequencing Sample Preparation Market, including Agilent Technologies, Inc., BGI, Bio-Rad Laboratories, Inc., CLC Bio, Eurofins GATC Biotech GmbH, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Foundation Medicine, Inc., GnuBio, Illumina, Inc., Knome, Inc., Life Technologies Corp., Macrogen, Inc., Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., Perkin Elmer, Inc., PierianDx, Qiagen, Quest Diagnostics Incorporated, and Thermo Fisher Scientific, Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Next-Generation Sequencing Sample Preparation Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Next-Generation Sequencing Sample Preparation Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Next-Generation Sequencing Sample Preparation Market?
  • 4. What is the competitive strategic window for opportunities in the Global Next-Generation Sequencing Sample Preparation Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Next-Generation Sequencing Sample Preparation Market?
  • 6. What is the market share of the leading vendors in the Global Next-Generation Sequencing Sample Preparation Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Next-Generation Sequencing Sample Preparation Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Define: Research Objective
  • 2.3. Determine: Research Design
  • 2.4. Prepare: Research Instrument
  • 2.5. Collect: Data Source
  • 2.6. Analyze: Data Interpretation
  • 2.7. Formulate: Data Verification
  • 2.8. Publish: Research Report
  • 2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing automation in NGS sample preparation
      • 5.1.1.2. Government & private organizations support for large-scale sequencing
      • 5.1.1.3. Improved reimbursement outline for NGS-based diagnostic tests
    • 5.1.2. Restraints
      • 5.1.2.1. Ethical concerns associated with NGS sample
    • 5.1.3. Opportunities
      • 5.1.3.1. Widening application of NGS
      • 5.1.3.2. Maximizing RNA quality for effective sequencing
    • 5.1.4. Challenges
      • 5.1.4.1. Challenges in NGS sample preparation
  • 5.2. Cumulative Impact of COVID-19

6. Next-Generation Sequencing Sample Preparation Market, by Workflow

  • 6.1. Introduction
  • 6.2. Automated Library Preparation
  • 6.3. Clonal Amplification
  • 6.4. NGS Library Preparation Kits
  • 6.5. Semi-automated Library Preparation

7. Next-Generation Sequencing Sample Preparation Market, by Application

  • 7.1. Introduction
  • 7.2. Agrigenomics & Forensics
  • 7.3. Clinical Investigation
  • 7.4. Consumer Genomics
  • 7.5. HLA Typing/Immune System Monitoring
  • 7.6. Metagenomics, Epidemiology & Drug Development
  • 7.7. Oncology
  • 7.8. Reproductive Health

8. Next-Generation Sequencing Sample Preparation Market, by End User

  • 8.1. Introduction
  • 8.2. Academic Research
  • 8.3. Clinical Research
  • 8.4. Hospitals & Clinics
  • 8.5. Pharma & Biotech Entities

9. Americas Next-Generation Sequencing Sample Preparation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Next-Generation Sequencing Sample Preparation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand

11. Europe, Middle East & Africa Next-Generation Sequencing Sample Preparation Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Key Player
  • 12.4. Competitive Scenario
    • 12.4.1. Merger & Acquisition
    • 12.4.2. Agreement, Collaboration, & Partnership
    • 12.4.3. New Product Launch & Enhancement
    • 12.4.4. Investment & Funding
    • 12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Agilent Technologies, Inc.
  • 13.2. BGI
  • 13.3. Bio-Rad Laboratories, Inc.
  • 13.4. CLC Bio
  • 13.5. Eurofins GATC Biotech GmbH
  • 13.6. Eurofins Scientific
  • 13.7. F. Hoffmann-La Roche Ltd.
  • 13.8. Foundation Medicine, Inc.
  • 13.9. GnuBio
  • 13.10. Illumina, Inc.
  • 13.11. Knome, Inc.
  • 13.12. Life Technologies Corp.
  • 13.13. Macrogen, Inc.
  • 13.14. Oxford Nanopore Technologies
  • 13.15. Pacific Biosciences of California, Inc.
  • 13.16. Perkin Elmer, Inc.
  • 13.17. PierianDx
  • 13.18. Qiagen
  • 13.19. Quest Diagnostics Incorporated
  • 13.20. Thermo Fisher Scientific, Inc.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
Back to Top
전화 문의
F A Q